1 min to read News Posted on February 13, 2023 Moody's confirms Amgen's Baa1 rating; outlook is negative – Moody's Moody's confirms Amgen's Baa1 rating; outlook is negative Moody's Source: Moody's confirms Amgen's Baa1 rating; outlook is negative – Moody's share tweet share SPACs: Are You Really Ready To Commit?What Will Crypto SPACs Look Like in 2023?How a SPAC works?Why Buy a SPAC Before It Identifies a Target? Tags: SPACs